Injectable biodegradable materials for orthopedic tissue engineering

Biomaterials

Volumn 21, Issue 23, 2000, Pages 2405-2412

  Temenoff, Johnna S ^a   Mikos, Antonios G ^a  

^a Rice University   (United States)

Author keywords

Biodegradable polymer; Bone; Cartilage; Ceramic; Injectable material; Tissue engineering

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADATION; BONE; CARTILAGE; CERAMIC MATERIALS; MECHANICAL PROPERTIES; ORTHOPEDICS; POLYMERS;

INJECTABLE BIOMATERIALS; TISSUE ENGINEERING;

BIOMATERIALS;

POLYMER;

BIOENGINEERING; BONE; CARTILAGE; CERAMICS; INJECTION; ORTHOPEDICS; PRIORITY JOURNAL; REVIEW;

EID: 0034580551     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(00)00108-3     Document Type: Article

References (70)

1. American Academy of Orthopedic Surgeons website. www.aaos.org.
2. Peter S.J., Nolley J.A., Widmer M.S., Merwin J.E., Yaszemski M.J., Yasko A.W., Engel P.S., Mikos A.G. In vitro degradation of a poly(propylene fumarate)/β-tricalcium phosphate composite orthopedic scaffold. Tissue Eng. 3:1997;207-215.
3. Thomson R.C., Wake M.C., Yaszemski M.J., Mikos A.G. Biodegradable polymer scaffolds to regenerate organs. Adv Polym Sci. 122:1995;245-274.
4. Yaszemski M.J., Payne R.G., Hayes W.C., Langer R., Mikos A.G. In vitro degradation of a poly(propylene fumarate)-based composite material. Biomaterials. 17:1996;2127-2130.
5. Yaszemski M.J., Payne R.G., Hayes W.C., Langer R., Mikos A.G. Evolution of bone transplantation. molecular, cellular and tissue strategies to engineer human bone Biomaterials. 17:1996;175-185.
6. Frayssinet P., Gineste L., Conte P., Fages J., Rouquet N. Short-term implantation of a DCPD-based calcium phosphate cement. Biomaterials. 19:1998;971-977.
7. Ikenaga M., Hardouin P., Lemaitre J., Andrianjatovo H., Flautre B. Biomechanical characterization of a biodegradable calcium phosphate hydraulic cement. a comparison with porous biphasic calcium phosphate ceramics J Biomed Mater Res. 40:1998;139-144.
8. Klein C.P.A.T., Dreissen A.A., de Groot K. Biodegradation behavior of various calcium phosphate materials in bone tissue. J Biomed Mater Res. 17:1983;769-784.
9. Daculsi G., LeGros R.Z., Nery E., Lynch K., Kerebel B. Transformation of biphasic calcium phosphate ceramics in vivo. ultrastructural and physicochemical characterization J Biomed Mater Res. 23:1989;883-894.
10. Gauthier O., Bouler J.-M., Weiss P., Bosco J., Daculsi G., Aguado E. Kinetic study of bone ingrowth and ceramic resorption associated with the implantation of different injectable calcium-phosphate bone substitutes. J Biomed Mater Res. 47:1999;28-35.
11. Dupraz A., Delecrin J., Moreau A., Pilet P., Passuti N. Long-term bone response to particulate injectable ceramic. J Biomed Mater Res. 42:1998;368-375.
12. Grimandi G., Weiss P., Millot F., Daculsi G. In vitro evaluation of a new injectable calcium phosphate material. J Biomed Mater Res. 39:1998;660-666.
13. Gauthier O., Boix D., Grimandi G., Aguado E., Bouler J.-M., Weiss P., Daculsi G. A new injectable phosphate biomaterial for immediate bone filling of extraction sockets. a preliminary study in dogs J Periodontol. 70:1999;375-383.
14. Ohura K., Bohner M., Hardouin P., Lemaitre J., Pasquier G., Flautre B. Resorption of, and bone formation from, new β-tricalcium phosphate-monocalcium phosphate cements. an in vivo study J Biomed Mater Res. 30:1996;193-200.
15. Munting E., Mirtchi A.A., Lemaitre J. Bone repair of defects filled with a phosphocalcic hydraulic cement. an in vivo study J Mater Sci Mater Med. 1993;337-344.
16. Miyamoto Y., Ishikawa K., Fukao H., Sawada M., Nagayama M., Kon M., Asaoka K. In vivo setting behaviour of fast-setting calcium phosphate cement. Biomaterials. 16:1995;855-860.
17. Miyamoto Y., Ishikawa K., Takechi M., Toh T., Yoshida Y., Nagayama M., Kon M., Asaoka K. Tissue response to fast-setting calcium phosphate cement in bone. J Biomed Mater Res. 37:1997;457-464.
18. Miyamoto Y., Ishikawa K., Takechi M., Toh T., Yuasa T., Nagayama M., Suzuki K. Histological and compositional evaluations of three types of calcium phosphate cements when implanted in subcutaneous tissue immediately after mixing. J Biomed Mater Res Appl Biomater. 48:1999;36-42.
19. Ishikawa K., Asaoka K. Estimation of ideal mechanical strength and critical porosity of calcium phosphate cement. J Biomed Mater Res. 29:1995;1537-1543.
20. Driessens F.C.M., Boltong M.G., Bermudez O., Planell J.A., Ginebra M.P., Fernandez E. Effective formulations for the preparation of calcium phosphate bone cements. J Mater Sci Mater Med. 5:1994;164-170.
21. Anseth K.S., Shastri V.R., Langer R. Photopolymerizable degradable polyanhydrides with osteocompatibility. Nature Biotech. 17:1999;156-159.
22. Miyamoto Y., Ishikawa K., Takechi M., Toh T., Yuasa T., Nagayama M., Suzuki K. Basic properties of calcium phosphate cement containing atelocollagen in its liquid or powder phases. Biomaterials. 19:1998;707-715.
23. Ishikawa K., Miyamoto Y., Kon M., Nagayama M., Asaoka K. Non-decay type fast-setting calcium phosphate cement. composite with sodium alginate Biomaterials. 16:1995;527-532.
24. Ishikawa K., Miyamoto Y., Takechi M., Toh T., Kon M., Nagayama M., Asaoka K. Non-decay type fast-setting calcium phosphate cement. hydroxyapatite putty containing an increased amount of sodium alginate J Biomed Mater Res. 36:1997;393-399.
25. Takechi M., Miyamoto Y., Ishikawa K., Toh T., Yuasa T., Nagayama M., Suzuki K. Initial histological evaluation of anti-washout type fast-setting calcium phosphate cement following subcutaneous implantation. Biomaterials. 19:1998;2057-2063.
26. Frankenburg E.P., Goldstein S.A., Bauer T.W., Harris S.A., Poser R.D. Biomechanical and Histological Evaluation of a Calcium Phosphate Cement. J Bone Joint Surg. 80-A:1998;1112-1124.
27. Constanz B.R., Ison I.C., Fulmer M.T., Poser R.D., Smith S.T., VanWagoner M., Ross J., Goldstein S.A., Jupiter J.B., Rosenthal D.I. Skeletal repair by in situ formation of the mineral phase of bone. Science. 267:1995;1796-1799.
28. Constanz B.R., Barr B.M., Ison I.C., Fulmer M.T., Baker J., McKinney L., Goodman S.B., Gunasekaren S., Delaney D.C., Ross J., Poser R.D. Histological, chemical, and crystallographic analysis of four calcium phosphate cements in different rabbit osseous sites. J Biomed Mater Res Appl Biomater. 43:1998;451-461.
29. Goodman S.B., Bauer T.W., Carter D., Casteleyn P.P., Goldstein S.A., Kyle R.F., Larsson S., Stakewich C.J., Swiontkowski M.F., Tencer A.F., Yetkinler D.N., Poser R.D. Norian SRS cement augmentation in hip fracture treatment. Clin Orthop Rel Res. 348:1998;42-50.
30. Kopylov P, Jonsson K, Thorugven KG. Aspenberg P. Injectable calcium phosphate in the treatment of distal radial fractures. J Hand Surg 1996;21B:768-71.
31. Food and Drug Administration (USA) website. www.fda.gov.
32. Knaack D., Goad M.E.P., Aiolova M., Rey C., Tofighi A., Chakravarthy P., Lee D.D. Resorbable calcium phosphate bone substitute. J Biomed Mater Res Appl Biomater. 43:1998;399-409.
33. Muggli D.S., Burkoth A.K., Anseth K.S. Crosslinked polyanhydrides for use in orthopedic applications. degradation behavior and mechanics J Biomed Mater Res. 46:1999;271-278.
34. Muggli D.S., Burkoth A.K., Keyser S.A., Lee H.R., Anseth K.S. Reaction behavior of biodegradable, photo-cross-linkable polyanhydrides. Macromolecules. 31:1998;4120-4125.
35. Shastri V.R., Marini R.P., Padera R.F., Kirchain S., Tarcha P., Langer R. Osteocompatibility of photopolymerizable anhydride networks. Mater Res Soc Symp Proc. 530:1998;93-98.
36. He S, Yaszemski MJ, Yasko AW, Engel PS, Mikos AG. Synthesis of biodegradable poly(propylene fumarate) networks with poly(propylene fumarate)-diacrylate monomers as cross-linking agents and characterization of their degradation products. Polymer, 2000, in press.
37. Peter S.J., Miller M.J., Yaszemski M.J., Mikos A.G. Poly(propylene fumarate). Domb A.J., Kost J., Wiseman D.M. Handbook of biodegradable polymers. 1997;87-97 Harwood Academic, Amsterdam.
38. Frazier D.D., Lathi V.K., Gerhart T.N., Altobelli D.E., Hayes W.C. In vivo degradation of a poly(propylene fumarate) biodegradable, particulate composite bone cement. Mater Res Soc Symp Proc. 394:1995;15-19.
39. Frazier D.D., Lathi V.K., Gerhart T.N., Hayes W.C. Ex vivo degradation of a poly(propylene glycol-fumarate) biodegradable particulate bone cement. J Biomed Mater Res. 35:1997;383-389.
40. Gresser J.D., Hsu S.-H., Nagaoka H., Lyons C.M., Nieratko D.P., Wise D.L., Barabino G.A., Trantolo D.J. Analysis of a vinyl pyrrolidone/poly(propylene fumarate) resorbable bone cement. J Biomed Mater Res. 29:1995;1241-1247.
41. Yaszemski M.J., Payne R.G., Hayes W.C., Langer R.S., Aufdemorte T.B., Mikos A.G. The ingrowth of new bone tissue and initial mechanical properties of a degrading polymeric composite scaffold. Tissue Eng. 1:1995;41-52.
42. Kharas G.B., Kamenetsky M., Simantirakis J., Beinlich K.C., Rizzo A.-M.T., Caywood G.A., Watson K. Synthesis and characterization of fumarate-based polyesters for use in bioresorbable bone cement composites. J Appl Polym Sci. 66:1997;1123-1137.
43. Peter S.J., Kim P., Yasko A.W., Yaszemski M.J., Mikos A.G. Crosslinking characteristics of an injectable poly(propylene fumarate)/β-tricalcium phosphate paste and mechanical properties of the crosslinked composite for use as a biodegradable bone cement. J Biomed Mater Res. 44:1999;314-321.
44. Peter S.J., Miller S.T., Zhu G., Yasko A.W., Mikos A.G. In vivo degradation of a poly(propylene fumarate)/β-tricalcium phosphate injectable composite scaffold. J Biomed Mater Res. 41:1998;1-7.
45. Pete S.J., Lu L., Kim D.J., Mikos A.G. Marrow stromal osteoblast function on a poly(propylene fumarate)/β-tricalcium phosphate biodegradable orthopedic composite. Biomaterials. 21:2000;1207-1213.
46. Payne R.G., Sivaram S.A., Babensee J.E., Yasko A.W., Yaszemski M.J., Mikos A.G. Temporary encapsulation of rat marrow osteoblasts in gelatin microspheres. Tissue Eng. 4:1998;497.
47. Jo S, Engel PS, Mikos AG. Synthesis of poly(ethylene glycol)-tethered poly(propylene-co-fumarate) and its modification with GRGD peptide. Polymer, 2000, in press.
48. Peter S.J., Lu L., Kim D.J., Stamatas G.N., Miller M.J., Yaszemski M.J., Mikos A.G. Effects of transforming growth factor-β1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates. J Biomed Mater Res. 50:2000;452-462.
49. Lu L., Stamatas G.N., Mikos A.G. Controlled release of transforming growth factor-β1 from biodegradable polymers. J Biomed Mater Res. 50:2000;44-56.
50. Cohen N.P., Foster R.J., Mow V.C. Composition and dynamics of articular cartilage. structure, function, and maintaining healthy state J Orthop Sports Phys Ther. 28:1998;203-215.
51. Buckwalter J.A., Mankin H.J. Articular cartilage. tissue design and chondrocyte-matrix interactions AAOS Inst Course Lect. 47:1998;477-486.
52. Athanasiou K.A., Rosenwasser M.P., Buckwalter J.A., Malinin T.I., Mow V.C. Interspecies comparisons of in situ intrinsic mechanical properties of distal femoral cartilage. J Orthop Res. 9:1991;330-340.
53. Athanasiou K.A., Agarwal A., Dzida F.J. Comparative study of the intrinsic mechanical properties of the human acetabular and femoral head cartilage. J Orthop Res. 12:1994;340-349.
54. Athanasiou K.A., Niederauer G.G., Schenck R.C.J. Biomechanical topography of human ankle cartilage. Ann Biomed Engr. 23:1995;697-704.
55. Coutts R.D., Sah R.L., Amiel D. Effect of growth factors on cartilage repair. AAOS Inst Course Lect. 46:1997;487-494.
56. Buckwalter J.A. Articular cartilage. injuries and potential for healing J Orthop Sports Phys Ther. 28:1998;192-202.
57. Solchaga L.A., Dennis J.E., Goldberg V.M., Caplan A.I. Hyaluronic acid-based polymers as cell carriers for tissue-engineered repair of bone and cartilage. J Orthop Res. 17:1999;205-213.
58. Wakitani S., Goto T., Pineda S.J., Young R.G., Mansour J.M., Caplan A.I., Goldberg V.M. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone J Surg. 76-A:1994;579-592.
59. Sims C.D., Butler P.E.M., Cao Y.L., Casanova R., Randolph M.A., Black A., Vacanti C.A., Yaremchuk M.J. Tissue engineered neocartilage using plasma derived polymer substrates and chondrocytes. Plast Reconstr Surg. 101:1998;1580-1585.
60. Hendrickson D.A., Nixon A.J., Grande D.A., Todhunter R.J., Minor R.M., Erb H., Lust G. Chondrocyte-fibrin matrix transplants for resurfacing extensive articular cartilage defects. J Orthop Res. 12:1994;485-497.
61. Paige K.T., Cima L.G., Yaremchuk M.J., Vacanti J.P., Vacanti C.A. Injectable cartilage. Plast Reconstr Surg. 96:1995;1390-1400.
62. Paige K.T., Cima L.G., Yaremchuk M.J., Schloo B.L., Vacanti J.P., Vacanti C.A. De novo cartilage generation using calcium alginate-chondrocyte constructs. Plast Reconstr Surg. 97:1996;168-180.
63. Kulseng B., Skjak-Braek G., Ryan L., Andersson A., King A., Faxvaag A., Espevik T. Transplantation of alginate microcapsules. Transplantation. 67:1999;978-984.
64. Sims C.D., Butler P.E.M., Casanova R., Lee B.T., Randolph M.A., Lee W.P.A., Vacanti C.A., Yaremchuk M.J. Injectable cartilage using polyethylene oxide polymer substrates. Plast Reconstr Surg. 98:1996;843-850.
65. Elisseeff J., Anseth K., Sims D., McIntosh W., Randolph M., Langer R. Transdermal photopolymerization for minimally invasive implantation. Proc Natl Acad Sci USA. 96:1999;3104-3107.
66. Suggs L.J., Payne R.G., Yaszemski M.J., Alemany L.B., Mikos A.G. Synthesis and characterization of a block copolymer consisting of poly(propylene fumarate) and poly(ethylene glycol). Macromolecules. 30:1997;4318-4323.
67. Suggs L.J., Kao E.Y., Palombo L.L., Krishnan R.S., Widmer M.S., Mikos A.G. Preparation and characterization of poly(propylene fumarate-co-ethylene glycol) hydrogels. J Biomater Sci Polym Edn. 9:1998;653-666.
68. Suggs L.J., Shive M.S., Garcia C.A., Anderson J.M., Mikos A.G. In vitro cytotoxicity and in vivo biocompatiblity of poly(propylene fumarate-co-ethylene glycol) Hydrogels. J Biomed Mater Res. 46:1999;22-32.
69. Suggs L.J., Krishnan R.S., Garcia C.A., Peter S.J., Anderson J.M., Mikos A.G. In vitro and in vivo degradation of poly(propylene fumarate-co-ethylene glycol) hydrogels. J Biomed Mater Res. 42:1998;312-320.
70. Suggs L.J., Mikos A.G. Development of poly(propylene fumarate-co-ethylene glycol) as an injectable carrier for endothelial cells. Cell Transplantation. 8:1999;345-350.